Print this page Print this page      Email this page Email this page     Text Size: A  A  A     Click Here to Sign In
Home > MS Treatment > MS Treatment Options > REBIF® (interferon beta-1a)

REBIF®

(interferon beta-1a)

  • REBIF is approved to decrease the number of relapses of the disease and slow down the occurrence of some of the physical disability that is common in people with MS.

View Clinical Benefits

Dosing regimen:
  • REBIF is self-injected three times a week.
Clinical Benefits
CLOSE

REBIF® (interferon beta-1a) Clinical Benefits

 

  • Reduce the number and frequency of relapses
  • Slow the progression of physical disability
Personalize Your Own MS ActiveSource Homepage
Register now to start using these helpful online tools.
  • My MS Memory Builder
  • My MS Calendar
  • My MS Logbook
 Create a profile 
Already have a profile? Sign In
Managing Treatment Side Effects All MS treatments have side effects. Get tips on how to manage them. Learn more
Staying on Treatment Find information on the importance of staying on treatment for MS. Learn more

Call an MS Support Specialist: 1.800.456.2255

Elan  |  Contact Us  |  Privacy Policy  |   Legal Disclaimer  |  Site Map

© 2009 Biogen Idec. All rights reserved. MSActiveSource is a registered trademark of Biogen Idec. MSActiveSource is sponsored by Biogen Idec and Elan Pharmaceuticals.

BIOGEN IDEC and the BIOGEN IDEC logo are registered trademarks of BIOGEN IDEC.
The Elan logo is a registered trademark of Elan Corporation, PLC.